Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin

about

Serelaxin Treatment Reduces Oxidative Stress and Increases Aldehyde Dehydrogenase-2 to Attenuate Nitrate Tolerance.Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination.

P2860

Q37712528-96579768-FAE6-4196-BDDF-132B4B3E1BE2 Q48205666-422C7546-2542-4AFC-8091-19E869853F6F

P2860

Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin

Item

http://www.wikidata.org/entity/Q37083919

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Involvement of Cyclic Guanosin ...... ifibrotic Effects of Serelaxin

@en

Involvement of Cyclic Guanosin ...... fibrotic Effects of Serelaxin.

@nl

type

Item

label

Involvement of Cyclic Guanosin ...... ifibrotic Effects of Serelaxin

@en

Involvement of Cyclic Guanosin ...... fibrotic Effects of Serelaxin.

@nl

prefLabel

Involvement of Cyclic Guanosin ...... ifibrotic Effects of Serelaxin

@en

Involvement of Cyclic Guanosin ...... fibrotic Effects of Serelaxin.

@nl

P1476

Involvement of Cyclic Guanosin ...... ifibrotic Effects of Serelaxin

@en

P2093

Elisabeth Schinner

http://www.w3.org/2001/XMLSchema#string

Franz Hofmann

http://www.w3.org/2001/XMLSchema#string

Frieder Kees

http://www.w3.org/2001/XMLSchema#string

Jens Schlossmann

http://www.w3.org/2001/XMLSchema#string

Lothar Faerber

http://www.w3.org/2001/XMLSchema#string

Veronika Wetzl

http://www.w3.org/2001/XMLSchema#string

P2860

Protein measurement with the Folin phenol reagent

Prevalence of chronic kidney disease in population-based studies: systematic review

TGF-beta signal transduction

Activation of orphan receptors by the hormone relaxin

Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2

Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model

TGF-beta signaling and the fibrotic response

Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy.

Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.

Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis.

P304

195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2016.00195

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27462268

http://www.w3.org/2001/XMLSchema#string

P932

4940422

http://www.w3.org/2001/XMLSchema#string

Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin

about

P2860

P2860

Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932